How might public health hold companies accountable for how their products affect human health? Thomas points to new arguments for public health and new coalitions that might yield greater human health.

Comprehensively understanding how the prevalence and severity of side effects, unmet needs, and barriers to supportive care affect quality of life in diverse ovarian cancer survivors remains a research gap and priority.

This seminar will explore disparities along the cancer continuum, discuss potential underlying mechanisms, and share ongoing work characterizing the impact of socioeconomic status on outcome.